XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.25.1

NET INCOME (LOSS) PER SHARE | 3 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
NET INCOME (LOSS) PER SHARE | NET INCOME (LOSS) PER SHARE Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income per share is computed in a similar manner, but it also includes the effect of potential common shares outstanding during the period, when dilutive. The following table presents the computation of basic and diluted net income (loss) per share for the periods presented:
|  |  | Three Months Ended March 31,
|  |  |  |  | 2025 |  | 2024 |  |
|  |  |  |  | (In thousands, except per share data)
Numerator: |  |  |  |  |  |  |  |  |
Net income (loss) |  |  |  |  | $ | 29,730 |  |  | $ | (16,097) |  |  |
Notes due 2028 and Notes due 2026 financing costs, net |  |  |  |  | 605 |  |  | — |  |  |
Adjusted net income (loss) |  |  |  |  | $ | 30,335 |  |  | $ | (16,097) |  |  |
Denominator: |  |  |  |  |  |  |  |  |
Shares used in basic per share amounts: |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding |  |  |  |  | 131,869 |  |  | 135,891 |  |  |
Shares used in diluted per share amounts: |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding used for basic calculation |  |  |  |  | 131,869 |  |  | 135,891 |  |  |
Effect of dilutive securities: |  |  |  |  |  |  |  |  |
Employee stock-based awards |  |  |  |  | 264 |  |  | — |  |  |
Notes due 2026 |  |  |  |  | 2,057 |  |  | — |  |  |
Notes due 2028 |  |  |  |  | 2,018 |  |  | — |  |  |
Weighted average common shares outstanding for diluted calculation |  |  |  |  | 136,208 |  |  | 135,891 |  |  |
Basic and diluted net income (loss) per share |  |  |  |  |  |  |  |  |
Net income (loss) per share, basic |  |  |  |  | $ | 0.23 |  |  | $ | (0.12) |  |  |
Net income (loss) per share, diluted |  |  |  |  | $ | 0.22 |  |  | $ | (0.12) |  |  |
Diluted earnings per share for the three months ended March 31, 2025 includes the dilutive effect of potentially dilutive common shares by application of the treasury stock method for stock options, RSUs, PSUs, ESPP, Notes due 2025, and includes potentially dilutive common shares by application of the if-converted method for the Notes due 2026 and Notes due 2028. To the extent these potential common shares are antidilutive, they are excluded from the calculation of diluted net income per share. Further, the Company under the relevant sections of the indentures, irrevocably may elect to settle principal in cash and any excess in cash or shares of the Company’s common stock for the Notes due 2026 and Notes due 2028. If and when the Company makes such election, there will be no adjustment to the net income and the Company will use the average share price for the period to determine the potential number of shares to be issued based upon assumed conversion to be included in the diluted share count. The Company's Notes due 2025 were convertible at any time from October 1, 2024, until the close of business on the second scheduled trading day immediately preceding the maturity date of March 1, 2025. Upon conversion, the Notes due 2025 were required to be settled using a combination settlement method, whereby the principal amount was paid in cash, and any excess conversion value was settled in shares of the Company's common stock. As a result of this settlement, no adjustment to net income was required for the three months ended March 31, 2025. For purposes of calculating diluted earnings per share, the Company utilized the average share price during the period from January 1, 2025 through March 1, 2025 to determine the potential number of shares issuable upon conversion and be included in the diluted share count. The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net income (loss) per share attributable to common stockholders because their effect would have been antidilutive:
|  |  | Three Months Ended March 31,
|  |  |  |  | 2025 |  | 2024 |  |
|  |  |  |  | (In thousands)
Employee stock-based awards |  |  |  |  | 3,071 |  |  | 1,656 |  |  |
Notes due 2025 |  |  |  |  | 323 |  |  | 1,253 |  |  |
Notes due 2026 |  |  |  |  | — |  |  | 2,057 |  |  |
2026 Warrants |  |  |  |  | 10,879 |  |  | 4,958 |  |  |
Notes due 2028 |  |  |  |  | — |  |  | 2,018 |  |  |
2028 Warrants |  |  |  |  | 10,675 |  |  | 4,865 |  |  |
Total |  |  |  |  | 24,948 |  |  | 16,807 |  |  |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration